Kemp Dolliver
Stock Analyst at Brookline Capital
(0.89)
# 2,798
Out of 4,412 analysts
16
Total ratings
30%
Success rate
-11.29%
Average return
Main Sectors:
14 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DARE Daré Bioscience | Downgrades: Hold | n/a | $0.31 | - | 1 | Apr 17, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Hold | n/a | $21.42 | - | 1 | Mar 19, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $8.43 | +272.48% | 1 | Jan 25, 2024 | |
| CYCC Cyclacel Pharmaceuticals | Downgrades: Hold | n/a | $1.51 | - | 1 | Dec 19, 2023 | |
| ONCT Oncternal Therapeutics | Upgrades: Buy | $40 | $8.71 | +359.24% | 2 | Dec 4, 2023 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $65.56 | +52.53% | 1 | Nov 30, 2023 | |
| EYEN Eyenovia | Initiates: Buy | $8 | $0.63 | +1,173.48% | 1 | Oct 17, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $4.42 | +1,189.62% | 2 | Oct 12, 2023 | |
| PROC Procaps Group | Downgrades: Hold | $4.5 | $2.73 | +65.01% | 1 | Sep 6, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $3.40 | +635.29% | 1 | May 18, 2023 | |
| ECOR electroCore | Initiates: Buy | $19 | $5.76 | +225.52% | 1 | Jan 13, 2023 | |
| SCYX SCYNEXIS | Assumes: Buy | $8 | $1.54 | +419.48% | 1 | Oct 21, 2022 | |
| VRCA Verrica Pharmaceuticals | Initiates: Buy | $20 | $6.87 | +191.12% | 1 | Mar 10, 2022 | |
| ICCM IceCure Medical | Initiates: Buy | $5.65 | $1.19 | +374.79% | 1 | Feb 2, 2022 |
Daré Bioscience
Apr 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Fusion Pharmaceuticals
Mar 19, 2024
Downgrades: Hold
Price Target: n/a
Current: $21.42
Upside: -
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $8.43
Upside: +272.48%
Cyclacel Pharmaceuticals
Dec 19, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.51
Upside: -
Oncternal Therapeutics
Dec 4, 2023
Upgrades: Buy
Price Target: $40
Current: $8.71
Upside: +359.24%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $65.56
Upside: +52.53%
Eyenovia
Oct 17, 2023
Initiates: Buy
Price Target: $8
Current: $0.63
Upside: +1,173.48%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $4.42
Upside: +1,189.62%
Procaps Group
Sep 6, 2023
Downgrades: Hold
Price Target: $4.5
Current: $2.73
Upside: +65.01%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $3.40
Upside: +635.29%
electroCore
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $5.76
Upside: +225.52%
SCYNEXIS
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $1.54
Upside: +419.48%
Verrica Pharmaceuticals
Mar 10, 2022
Initiates: Buy
Price Target: $20
Current: $6.87
Upside: +191.12%
IceCure Medical
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $1.19
Upside: +374.79%